Trial Profile
A Phase 4, Open Label, Study of Safety and Effectiveness of GRALISE (Gabapentin) Tablets in the Treatment of Patients With Postherpetic Neuralgia in Clinical Practice.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Nov 2018
Price :
$35
*
At a glance
- Drugs Gabapentin (Primary)
- Indications Postherpetic neuralgia
- Focus Therapeutic Use
- Sponsors Assertio Therapeutics; Depomed
- 23 Sep 2015 Results of a pooled data analysis from patients, enrolled in two phase 3 randomised, double-blind, placebo-controlled studies (81-0045 and 81-0062) and one phase 4 study (81-0067) published in the Journal of Pain.
- 03 May 2014 Results from a pooled analysis presented at the 33rd Annual Scientific Meeting of the American Pain Society.
- 10 May 2012 Actual patient number 201 added as reported by ClinicalTrials.gov.